Nos publications

Découvrez nos dernières ressources, idées et avis d’experts. Rubrique regroupant nos réflexions sur nos différents secteurs d’expertises.

Tendances

The Growth Blueprint podcast
Automotive Study
The new economics of neobanking
Better Health
Global Pricing Study 2025
Tariffs, pricing, and power
IA Generative
40 years of Better Growth in industrials
Better Growth
Simon-Kucher insights: Mastering private insurer negotiations in MENA
Feb 17, 2026 | Blog

Mastering private insurer negotiations in MENA

Healthcare & Life Sciences Healthcare Providers
MFN stress test blog
Feb 17, 2026 | Blog

MFN as a stress test for pharma price governance

Healthcare & Life Sciences
Simon-Kucher insights: End-to-end revenue management in medtech
Feb 11, 2026 | Blog

End-to-end revenue management in medtech

Healthcare & Life Sciences Diagnostics
Launch sequencing blog
Feb 09, 2026 | Blog

The evolution of global launch sequencing in pharma

Healthcare & Life Sciences Pharma & Biotechnology
Europe
MFN TSPE blog header
Feb 02, 2026 | Blog

MFN pricing: Implications for pharma

Healthcare & Life Sciences Pharma & Biotechnology
France
Simon-Kucher insights: France’s drug pricing and market access outlook 2026
Jan 22, 2026 | Blog

France’s drug pricing and market access outlook 2026

Healthcare & Life Sciences Pharma & Biotechnology
Americas
US P&MA
Jan 13, 2026 | Blog

US drug pricing in 2026: A new era

Healthcare & Life Sciences Pharma & Biotechnology
Simon-Kucher insights_Strategic indication-selection for early drug development
Jan 05, 2026 | Perspective | Whitepaper

Strategic indication-selection for early-stage drug development

Healthcare & Life Sciences Pharma & Biotechnology
Middle east & APAC
blog_China_NRDL_Readout
Dec 19, 2025 | Blog

NRDL 2025 readout: New listings

Healthcare & Life Sciences Pharma & Biotechnology
Global
Healthcare and life sciences trends 2026
Dec 16, 2025 | Blog

Healthcare and life sciences trends 2026

Healthcare & Life Sciences Pharma & Biotechnology
Americas
Simon-Kucher insights: Winners from the latest IRA price negotiation round
Dec 15, 2025 | Blog

Winners from the latest IRA price negotiation round

Healthcare & Life Sciences Pharma & Biotechnology
Global
Six watchouts for pharma
Dec 11, 2025 | Blog

Six watchouts for pharma in precision medicine

Healthcare & Life Sciences Diagnostics
Christian and Robert
Dec 11, 2025 | Multimedia

MFN, EU JCA & Equitable access: 2026 global pharma and biotech

Healthcare & Life Sciences Medtech
Americas
Simon-Kucher insights: Comparing IPAY 2027 to IPAY 2026 outcomes
Dec 03, 2025 | Blog

Comparing IPAY 2027 to IPAY 2026 outcomes

Healthcare & Life Sciences Pharma & Biotechnology
Americas
mfn
Nov 26, 2025 | Blog

Medicare MFPs versus MFN Pricing

Healthcare & Life Sciences Pharma & Biotechnology
Middle east & APAC
Simon-Kucher insights: Rethinking healthcare access in emerging markets
Nov 26, 2025 | Blog

Rethinking healthcare access in emerging markets

Healthcare & Life Sciences Pharma & Biotechnology
Langue
Rechercher